Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K103037
    Date Cleared
    2012-04-17

    (551 days)

    Product Code
    Regulation Number
    862.1510
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Product Code :

    NGJ

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The IND Urinary Tract Infection (UTI) Test Strips are intended for qualitative detection of nitrite and leukocytes in urine as an aid in the screening of urinary tract infection in persons with signs and symptoms of urinary tract infection. Testing of urine is performed by urinating into a sample cup and briefly dipping the test strip into it. This test is intended for over-the-counter home use only.

    Device Description

    Not Found

    AI/ML Overview

    Here's an analysis of the provided FDA 510(k) summary, specifically looking for acceptance criteria and study details.

    Crucial Note: The provided document is an FDA 510(k) clearance letter and an "Indications for Use" statement. It does not contain the detailed study report, acceptance criteria, or performance data itself. FDA clearance letters only state that the device has been found substantially equivalent to a predicate device. To get the information you're asking for, one would typically need access to the full 510(k) submission, which is not usually publicly available in this level of detail.

    Therefore, many of your questions cannot be answered from the provided text. I will indicate where the information is missing.


    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    (Not provided in the clearance letter)(Not provided in the clearance letter; the letter only indicates clearance, not specific performance metrics.)

    Explanation: The FDA clearance letter for K103037 for the "IND Urinary Tract Infection (UTI) Test Strips" does not detail the specific acceptance criteria or the reported device performance metrics (e.g., sensitivity, specificity) from the studies conducted. This information would typically be found in the full 510(k) submission's performance section.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample size for test set: Not provided.
    • Data Provenance (country of origin, retrospective/prospective): Not provided.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

    • Number of experts: Not provided.
    • Qualifications of experts: Not provided.

    4. Adjudication Method for the Test Set

    • Adjudication method: Not provided.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done

    • MRMC Study: Unlikely, as this is a diagnostic test strip for over-the-counter home use, not an imaging device typically involving multiple human readers interpreting complex images. The device is intended for direct user interpretation. Therefore, a traditional MRMC study as commonly understood for AI in medical imaging would not be applicable or expected.
    • Effect size of improvement with AI vs. without AI: Not applicable, as this is a standalone test strip, not an AI-assisted interpretation system for human readers.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    • Standalone Performance: Yes, implicitly. As a chemical test strip, its performance is inherently "standalone" in that it provides a direct result (color change) based on chemical reactions, without an algorithmic interpretation layer in the same way an AI software would operate. The user directly observes the result. The studies would have evaluated the accuracy of these chemical reactions against a reference method.

    7. The Type of Ground Truth Used

    • Type of Ground Truth: While not explicitly stated in this document, for a UTI test strip detecting nitrite and leukocytes, the ground truth would almost certainly be established through laboratory-based microbiological urine culture (for confirming actual UTI presence and specific pathogens) and potentially microscopic analysis of urine sediment (for leukocyte presence).

    8. The Sample Size for the Training Set

    • Sample size for training set: Not provided. For a non-AI diagnostic strip, "training set" isn't a conventional term in the same way as for machine learning. Instead, product development and optimization might involve iterative testing, but this wouldn't typically be called a "training set" in the context of FDA submissions for such devices.

    9. How the Ground Truth for the Training Set was Established

    • Ground truth for training set: Not provided. As noted above, the concept of a "training set" with established ground truth is less directly applicable for this type of chemical diagnostic strip. Optimization and development would rely on comparison to established laboratory methods.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1